Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ASP2151

Known as: ASP 2151 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
ASP2151 (amenamevir) is a helicase-primase inhibitor against herpes simplex virus 1 (HSV-1), HSV-2, and varicella zoster virus… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
ASP2151 (amenamevir) is a helicase-primase complex inhibitor with antiviral activity against herpes simplex virus HSV-1, HSV-2… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
Review
2013
Review
2013
Varicella-zoster virus (VZV) causes two distinct diseases, varicella (chickenpox) and shingles (herpes zoster). Chickenpox occurs… Expand
Is this relevant?
2013
2013
Aims To determine the efficacy of a new helicase-primase inhibitor, ASP2151, for treating herpetic keratitis. Methods Murine… Expand
Is this relevant?
2012
2012
BACKGROUND Current therapies for genital herpes have only partial efficacy. Helicase-primase inhibitors are novel, potent… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2012
2012
ASP2151 was developed as a novel inhibitor of herpes simplex virus (HSV) and varicella-zoster virus helicase-primase. The anti… Expand
Is this relevant?
2012
2012
ASP2151 (amenamevir) is a helicase-primase inhibitor against herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2012
2012
ASP2151 is an antiherpes agent targeting the helicase-primase complex of herpes simplex virus (HSV)-1, HSV-2, and varicella… Expand
Is this relevant?
2011
2011
ASP2151 is a herpesvirus helicase-primase inhibitor with antiviral activity against varicella zoster virus and herpes simplex… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVES To evaluate and describe the anti-herpesvirus effect of ASP2151, amenamevir, a novel non-nucleoside oxadiazolylphenyl… Expand
Is this relevant?